TALPHERA, INC. — Director's Dealing 2017

Oct 20, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2017-10-19

Reporting Person: Dasu Badri N (Chief Engineering Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-10-19	Common Stock	M	37500	$1.20	Acquired	74390	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-10-19	Stock Option (Right to Buy)	$1.20	M	37500	Disposed	2017-10-25	Common Stock (37500)	Direct

Footnotes

F1: Balance includes non-reportable acquisition of 14,360 shares of Common Stock through the Company's Employee Stock Purchase Plan.

F2: Fully vested.